CASI Pharmaceuticals Income Statement (2020-2025) | CASIF

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 9.03M8.55M10.21M10.26M8.35M9.82M8.84M6.87M3.41M3.98M7.79M13.36M6.24M4.17M3.08M7.22M
Cost of Revenue (Quarter) 3.76M3.55M4.25M4.27M3.38M3.99M3.65M2.81M1.60M1.91M3.75M10.13M2.62M2.12M2.37M3.53M
Gross Profit (Quarter) 5.30M5.02M5.97M10.99M4.97M5.83M5.19M4.06M1.81M2.07M4.04M3.23M3.62M2.06M0.71M3.69M
Operating items
Research & Development (Quarter) 3.99M3.85M3.90M-27.74M2.53M2.61M2.40M2.31M-2.48M-1.25M-1.52M14.17M-1.94M-1.72M-1.41M1.24M
Selling, General & Administrative (Quarter) 5.33M5.52M4.85M-39.14M5.75M7.70M5.52M6.42M-4.81M-5.94M-5.70M40.03M-7.70M-6.08M-4.93M9.56M
Other Operating Expenses (Quarter) 2.94M2.04M2.93M-29.78M3.90M4.86M2.37M-1.25M-3.97M-3.66M-5.29M31.19M-4.36M-5.38M-5.04M5.72M
Operating Expenses (Quarter) 12.26M11.41M11.68M-96.67M12.18M15.18M10.29M7.49M-11.26M-10.86M-12.51M85.39M-14.00M-13.18M-11.38M16.51M
Operating Income (Quarter) -6.96M-6.39M-5.72M-14.97M-7.21M-9.35M-5.09M16.13M-9.45M-8.79M-8.46M-12.91M-10.38M-11.12M-10.68M-77.19M
EBIT (Quarter) -6.96M-6.39M-5.72M-14.97M-7.21M-9.35M-5.09M16.13M-9.45M-8.79M-8.46M-12.91M-10.38M-11.12M-10.68M-77.19M
Non-operating items
Interest & Investment Income (Quarter) 0.10M-0.06M0.50M-0.01M-0.19M-0.38M-0.59M-0.87M-0.20M-0.44M0.64M
Other Non Operating Income (Quarter) -0.33M-1.35M-0.64M5.57M-0.06M0.04M-0.15M1.64M-0.23M0.27M-0.38M0.16M-0.15M-0.41M-0.43M-3.15M
Non Operating Income (Quarter) 0.04M0.01M0.01M-0.02M1.34M0.01M0.47M-2.74M0.16M0.02M0.02M0.01M
Net income details
EBT (Quarter) -6.96M-6.39M-5.62M-15.03M-7.21M-9.35M-4.59M16.12M-9.65M-9.17M-9.05M-13.79M-10.58M-11.57M-10.04M-77.19M
Tax Provisions (Quarter) 0.08M
Profit After Tax (Quarter) -8.40M-7.49M-5.02M61.17M-5.83M-10.07M-4.47M-6.59M-9.53M-6.96M-8.39M-14.37M10.75M-13.38M-10.88M-83.07M
Equity Income (Quarter) -0.14M-0.01M-0.01M-0.00M-0.17M-1.12M2.81M-0.27M-2.17M4.36M-2.36M
Net Income - Minority (Quarter) -33.90M-33.90M
Income from Non-Controlling Interests (Quarter) -0.42M-0.55M-0.74M-7.04M-0.67M-0.59M-0.60M-0.74M
Income from Continuing Operations (Quarter) -6.96M-6.39M-5.62M-15.03M-7.21M-9.43M-4.59M16.12M-9.65M-9.17M-9.05M-13.79M-10.58M-11.57M-10.04M-77.19M
Consolidated Net Income (Quarter) -6.96M-6.39M-5.62M-15.03M-7.21M-9.43M-4.59M16.12M-9.65M-9.17M-9.05M-13.79M-10.58M-11.57M-10.04M-77.19M
Income towards Parent Company (Quarter) -6.96M-6.39M-39.52M-48.93M-7.21M-9.43M-4.59M16.12M-9.65M-9.17M-9.05M-13.79M-10.58M-11.57M-10.04M-77.19M
Net Income towards Common Stockholders (Quarter) -6.96M-6.39M-39.52M-48.93M-7.21M-9.43M-4.59M16.12M-9.65M-9.17M-9.05M-13.79M-10.58M-11.57M-10.04M-77.19M
Additional items
EPS (Basic) (Quarter) -0.50-0.47-2.89-0.02M-0.54-0.711.21-9.65-9.17-0.90-0.02M-5.78-5.02-4.16
EPS (Weighted Average and Diluted) (Quarter) 1.21-0.72-0.90-0.68-4.16
Shares Outstanding (Weighted Average) (Quarter) 0.00M13.61M13.80M13.70M13.67M0.00M13.34M13.34M13.36M1.00M1.00M15.34M690.002.00M2.00M18.54M
Shares Outstanding (Diluted Average) (Quarter) 11.05M13.61M13.36M13.38M15.34M15.49M18.54M
EBITDA (Quarter) -8.15M-11.03M-8.15M-17.43M-5.63M-12.25M-4.64M49.89M9.43M-7.28M-8.44M64.99M-11.20M-13.39M-10.91M-77.19M
Tax Rate (Quarter) -0.86%